Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D

• Pubblicazione: [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2011
• Descrizione fisica: 1 online resource (iv, 22 pages) : color illustrations
• Soggetto topico: Medicare; Medicaid; Pharmaceutical services insurance - United States - Auditing; Drugs - Prices - United States; Brand name products - Prices - United States
• Note generali: Title from title screen (viewed June 23, 2016).; "August 2011."; "OEI-03-10-00320."
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D
• Titolo autorizzato: Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910707229603321
• Lo trovi qui: Univ. Federico II